BANK OF AMERICA CORP /DE/ - IMMUNOCELLULAR THERAPEUTICS ownership

IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 37 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q3 2013. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of IMMUNOCELLULAR THERAPEUTICS
ValueSharesWeighting
Q3 2016$02,775
+155.8%
0.00%
Q2 2016$01,085
-13.2%
0.00%
Q1 2016$01,250
+733.3%
0.00%
Q3 2015$0
-100.0%
150
-96.2%
0.00%
Q3 2014$4,0000.0%4,0000.0%0.00%
Q2 2014$4,0004,000
+708.1%
0.00%
Q4 2013$0
-100.0%
495
-83.5%
0.00%
Q3 2013$8,000
-95.5%
3,000
-96.8%
0.00%
Q2 2013$179,00092,3860.00%
Other shareholders

There were no reported owners of IMMUNOCELLULAR THERAPEUTICS in Q3 2013.

NameSharesValueWeighting ↓
View complete list of IMMUNOCELLULAR THERAPEUTICS shareholders